Evidence map›Paper›PMID 36387696›Full record

ArticleJournal of family medicine and primary care2022

Clinical diversities of patient eye care in para-COVID-19 era in Western Odisha.

Tarun K Panda, Priyadarsini Nanda

Abstract read
In one paragraph

Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tarun K PandaDepartment of Ophthalmology, Bhima Bhoi Medical College and Hospital, Balangir, Odisha, India.
Priyadarsini NandaDepartment of Ophthalmology, Bhima Bhoi Medical College and Hospital, Balangir, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronavirus disease (COVID-19) pandemic had an unprecedented effect on eye care services. The present study was conducted to assess the varied eye diseases and care around COVID-19 pandemic. Methods: This retrospective study was conducted at BBMCH, Balangir, Ophthalmology Department, Western Odisha, from September 2019 to May 2021 in three phases (i.e., September 2019 to March 2020, April to October 2020, November 2020 to March 2021). The total OPD consultations and emergency eye surgeries conducted around the COVID-19 period were retrieved from direct attendance in the OPD register, references, or tele-consultation. Results: Cumulative OPD eye consultations were found to be 13000, 3700, 7200 in pre-COVID, COVID and post-COVID period, respectively. Marked decrease in OPD cases (70%) was noticed in peak COVID period (April 2020 to October 2020) followed by slight increase during November 2020 to May 2021 i.e., (40% decrease). Allergic conjunctivitis was the commonest presentation in pre-COVID era, as compared to refractive error in COVID period. In post-COVID period, referrals, follow up cases, pending old surgical cases, red eyes formed major chunk of OPD attendance. Only 30% emergency cases underwent surgery during peak COVID, (Trauma cases, lens induced glaucoma, hypermature cataract, MLC cases, and one-eyed patients). But during post-COVID period this rose to 60%. Eight pediatric patients with intracorneal foreign body were given urgent treatment. Conclusion: Due to government guidelines and lockdown restrictions, majority (65%) of patients could not receive adequate treatment. But relaxation of rules in post-COVID period increased patient load to 75%.

Indexed as

COVID-19 eralimited manpowerlockdownPPE kitteleconsultationWHO

Identifiers

PMID36387696
PMCPMC9648292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.